Evaluation of chargeable amino acids effects on intractable epileptic patients
Phase 2
- Conditions
- Epilepsy.Epilepsy
- Registration Number
- IRCT201112178436N1
- Lead Sponsor
- eurology Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion criterion: all epileptic patients that do not have any responce to antiepileptic drug.
Exclusion criteria: pregnant women; lactating women; history of psychiatric diseas; viral infection and other seriuos diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Epileptic attacks. Timepoint: Two weeks. Method of measurement: Number of attacks.
- Secondary Outcome Measures
Name Time Method The number of seizure attacks. Timepoint: For three weeks ( one before and one in first week an other in second week). Method of measurement: The number of seizure attacks reported by patients or family.